Trials / Conditions / ER-Negative PR-Negative HER2-Negative Breast Cancer
ER-Negative PR-Negative HER2-Negative Breast Cancer
3 registered clinical trials studyying ER-Negative PR-Negative HER2-Negative Breast Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC NCT03361800 | UNC Lineberger Comprehensive Cancer Center | EARLY_Phase 1 |
| Withdrawn | A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Canc NCT02685306 | Peregrine Pharmaceuticals | Phase 2 |
| Completed | Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC NCT02531425 | OncoSec Medical Incorporated | Phase 1 |